Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 34(28): 3252-9, 2016 06 14.
Artigo em Inglês | MEDLINE | ID: mdl-27177945

RESUMO

Malaria transmission blocking (TB) vaccines (TBVs) directed against proteins expressed on the sexual stages of Plasmodium parasites are a potentially effective means to reduce transmission. Antibodies induced by TBVs block parasite development in the mosquito, and thus inhibit transmission to further human hosts. The ookinete surface protein P25 is a primary target for TBV development. Recently, transient expression in plants using hybrid viral vectors has demonstrated potential as a strategy for cost-effective and scalable production of recombinant vaccines. Using a plant virus-based expression system, we produced recombinant P25 protein of Plasmodium vivax (Pvs25) in Nicotiana benthamiana fused to a modified lichenase carrier protein. This candidate vaccine, Pvs25-FhCMB, was purified, characterized and evaluated for immunogenicity and efficacy using multiple adjuvants in a transgenic rodent model. An in vivo TB effect of up to a 65% reduction in intensity and 54% reduction in prevalence was observed using Abisco-100 adjuvant. The ability of this immunogen to induce a TB response was additionally combined with heterologous prime-boost vaccination with viral vectors expressing Pvs25. Significant blockade was observed when combining both platforms, achieving a 74% and 68% reduction in intensity and prevalence, respectively. This observation was confirmed by direct membrane feeding on field P. vivax samples, resulting in reductions in intensity/prevalence of 85.3% and 25.5%. These data demonstrate the potential of this vaccine candidate and support the feasibility of expressing Plasmodium antigens in a plant-based system for the production of TBVs, while demonstrating the potential advantages of combining multiple vaccine delivery systems to maximize efficacy.


Assuntos
Vacinas Antimaláricas/imunologia , Malária Vivax/prevenção & controle , Proteínas de Protozoários/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Homólogo 5 da Proteína Cromobox , Feminino , Imunização Secundária , Camundongos Endogâmicos BALB C , Plantas Geneticamente Modificadas , Plasmodium vivax , Proteínas Recombinantes/imunologia , Nicotiana , Vacinas de Subunidades Antigênicas/imunologia , Vacinas Sintéticas/imunologia
2.
Artigo em Inglês | MEDLINE | ID: mdl-22134037

RESUMO

Several studies indicated that biopharmaceuticals based on the recombinant protein E7 of human papillomavirus (HPV) can serve as therapeutic vaccines preventing the development of cancer in women infected with high-risk types of HPV such as HPV16. Here, we report effective extraction and purification of a plant-produced E7GGG-lichenase fusion protein, an HPV16 subunit vaccine candidate, from Nicotiana benthamiana plants, to a high yield. The target contains the modified HPV16 E7 protein internally fused to the surface loop of a truncated, hexa-His- and KDEL-tagged variant of bacterial lichenase, and has been previously shown to possess anti-cancer activity in an animal model. We purified the protein using a combination of immobilized metal-ion affinity chromatography and gel filtration. The achieved purity of the final product was 99% as confirmed by Coomassie or SYPRO Ruby staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by analytical size exclusion chromatography coupled with multi-angle laser light scattering. The overall yield was 50% corresponding to 0.1g of protein per 1 kg plant biomass. Only slight changes in these parameters were observed during the process scale-up from 50 g to 1 kg of processed leaf biomass.


Assuntos
Papillomavirus Humano 16/química , Proteínas E7 de Papillomavirus/química , Vacinas contra Papillomavirus/química , Proteínas Recombinantes de Fusão/química , Western Blotting , Soluções Tampão , Cromatografia em Gel , Cromatografia por Troca Iônica , Eletroforese em Gel de Poliacrilamida , Glicosídeo Hidrolases/metabolismo , Papillomavirus Humano 16/imunologia , Peso Molecular , Proteínas E7 de Papillomavirus/imunologia , Proteínas E7 de Papillomavirus/isolamento & purificação , Vacinas contra Papillomavirus/metabolismo , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/isolamento & purificação , Nicotiana/química , Nicotiana/virologia , Vacinas de Subunidades Antigênicas/química , Vacinas de Subunidades Antigênicas/imunologia
3.
Vaccine ; 20(25-26): 3155-64, 2002 Aug 19.
Artigo em Inglês | MEDLINE | ID: mdl-12163267

RESUMO

A new approach to the production and delivery of vaccine antigens is the use of engineered amino virus-based vectors. A chimeric peptide containing antigenic determinants from rabies virus glycoprotein (G protein) (amino acids 253-275) and nucleoprotein (N protein) (amino acids 404-418) was PCR-amplified and cloned as a translational fusion product with the alfalfa mosaic virus (AlMV) coat protein (CP). This recombinant CP was expressed in two plant virus-based expression systems. The first one utilized transgenic Nicotiana tabacum cv. Samsun NN plants providing replicative functions in trans for full-length infectious RNA3 of AlMV (NF1-g24). The second one utilized Nicotiana benthamiana and spinach (Spinacia oleracea) plants using autonomously replicating tobacco mosaic virus (TMV) lacking native CP (Av/A4-g24). Recombinant virus containing the chimeric rabies virus epitope was isolated from infected transgenic N. tabacum cv. Samsun NN plants and used for parenteral immunization of mice. Mice immunized with recombinant virus were protected against challenge infection. Based on the previously demonstrated efficacy of this plant virus-based experimental rabies vaccine when orally administered to mice in virus-infected unprocessed raw spinach leaves, we assessed its efficacy in human volunteers. Three of five volunteers who had previously been immunized against rabies virus with a conventional vaccine specifically responded against the peptide antigen after ingesting spinach leaves infected with the recombinant virus. When rabies virus non-immune individuals were fed the same material, 5/9 demonstrated significant antibody responses to either rabies virus or AlMV. Following a single dose of conventional rabies virus vaccine, three of these individuals showed detectable levels of rabies virus-neutralizing antibodies, whereas none of five controls revealed these antibodies. These findings provide clear indication of the potential of the plant virus-based expression systems as supplementary oral booster for rabies vaccinations.


Assuntos
Glicoproteínas/imunologia , Nicotiana/metabolismo , Nucleoproteínas/imunologia , Vacina Antirrábica/biossíntese , Vírus da Raiva/imunologia , Spinacia oleracea/metabolismo , Proteínas Virais/imunologia , Administração Oral , Vírus do Mosaico da Alfafa/genética , Animais , Anticorpos Antivirais/biossíntese , Anticorpos Antivirais/imunologia , Proteínas do Capsídeo/fisiologia , Vírus Defeituosos/genética , Alimentos , Glicoproteínas/biossíntese , Glicoproteínas/genética , Humanos , Camundongos , Camundongos Endogâmicos C3H , Testes de Neutralização , Nucleoproteínas/biossíntese , Nucleoproteínas/genética , Folhas de Planta , Plantas Geneticamente Modificadas/metabolismo , Vacina Antirrábica/genética , Vacina Antirrábica/imunologia , Vacina Antirrábica/isolamento & purificação , Vírus da Raiva/genética , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Especificidade da Espécie , Spinacia oleracea/genética , Nicotiana/genética , Vírus do Mosaico do Tabaco/genética , Vacinação/métodos , Vacinas de Subunidades Antigênicas/biossíntese , Vacinas de Subunidades Antigênicas/genética , Vacinas de Subunidades Antigênicas/imunologia , Vacinas de Subunidades Antigênicas/isolamento & purificação , Vacinas Sintéticas/biossíntese , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologia , Vacinas Sintéticas/isolamento & purificação , Proteínas Virais/biossíntese , Proteínas Virais/genética
4.
FASEB J ; 14(14): 2323-8, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11053254

RESUMO

Human respiratory syncytial virus (RSV) is the primary cause of respiratory infection in infants worldwide. Currently there is no available vaccine, although studies in animal models have demonstrated protective immunity induced by an epitope of the RSV G-protein representing amino acids 174-187. Two peptides containing amino acids 174-187 of the G-protein of the human RSV A2 strain (NF1-RSV/172-187 and NF2-RSV/170-191) were separately engineered as translational fusions with the alfalfa mosaic virus coat protein and individually expressed in Nicotiana tabacum cv. Samsun NN plants through virus infection. RSV G-protein peptides were expressed in infected plant tissues at significant levels within 2 wk of inoculation and purified as part of recombinant alfalfa mosaic virions. BALB/c mice immunized intraperitoneally with three doses of the purified recombinant viruses showed high levels of serum antibody specific for RSV G-protein and were protected against infection with RSV Long strain.


Assuntos
Antígenos Virais/imunologia , Plantas/imunologia , Vírus Sincicial Respiratório Humano/imunologia , Vacinas Virais/imunologia , Sequência de Aminoácidos , Animais , Antígenos Virais/genética , Antígenos Virais/ultraestrutura , Sequência de Bases , DNA Recombinante/genética , Feminino , Regulação da Expressão Gênica , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Plantas/genética , Plantas Geneticamente Modificadas , Plantas Tóxicas , Vírus Sincicial Respiratório Humano/genética , Nicotiana/genética , Nicotiana/imunologia , Transfecção , Vacinação , Vacinas Virais/genética
5.
Proc Natl Acad Sci U S A ; 96(5): 2549-53, 1999 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-10051680

RESUMO

Alfalfa mosaic virus (AlMV) coat protein is involved in systemic infection of host plants, and a specific mutation in this gene prevents the virus from moving into the upper uninoculated leaves. The coat protein also is required for different viral functions during early and late infection. To study the role of the coat protein in long-distance movement of AlMV independent of other vital functions during virus infection, we cloned the gene encoding the coat protein of AlMV into a tobacco mosaic virus (TMV)-based vector Av. This vector is deficient in long-distance movement and is limited to locally inoculated leaves because of the lack of native TMV coat protein. Expression of AlMV coat protein, directed by the subgenomic promoter of TMV coat protein in Av, supported systemic infection with the chimeric virus in Nicotiana benthamiana, Nicotiana tabacum MD609, and Spinacia oleracea. The host range of TMV was extended to include spinach as a permissive host. Here we report the alteration of a host range by incorporating genetic determinants from another virus.


Assuntos
Vírus do Mosaico da Alfafa/genética , Capsídeo/genética , Vírus do Mosaico do Tabaco/genética , Vírus do Mosaico da Alfafa/metabolismo , Sequência de Aminoácidos , Capsídeo/biossíntese , Capsídeo/química , Clonagem Molecular , Genoma Viral , Dados de Sequência Molecular , Doenças das Plantas , Folhas de Planta , Plantas Tóxicas , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Spinacia oleracea/virologia , Nicotiana/virologia , Transcrição Gênica
6.
J Immunol Methods ; 220(1-2): 69-75, 1998 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-9839927

RESUMO

We have used a tobacco mosaic virus-based vector to express monoclonal antibody (mAb) CO17-1A, directed to a colon cancer antigen, in plants. Genes encoding heavy and light chains of this antibody were introduced independently into the tobacco mosaic virus vector. Upon co-infection of Nicotiana benthamiana plants with both recombinant virus constructs, genes for heavy and light chains were expressed and assembled into a full-length antibody. A functional plant-expressed antibody was detected by ELISA and immunoblot in extracts from systemically infected leaves. This is the first report on the use of a plant virus vector to express and assemble a full-size antibody.


Assuntos
Anticorpos Monoclonais/biossíntese , Anticorpos Antineoplásicos/biossíntese , Neoplasias do Colo/imunologia , Vetores Genéticos/genética , Nicotiana/imunologia , Plantas Tóxicas , Vírus do Mosaico do Tabaco/genética , Anticorpos Monoclonais/genética , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/isolamento & purificação , Anticorpos Antineoplásicos/genética , Anticorpos Antineoplásicos/imunologia , Anticorpos Antineoplásicos/isolamento & purificação , Western Blotting , Clonagem Molecular , Ensaio de Imunoadsorção Enzimática , Genes de Imunoglobulinas , Humanos , Cadeias Pesadas de Imunoglobulinas/biossíntese , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias Leves de Imunoglobulina/biossíntese , Cadeias Leves de Imunoglobulina/genética , Folhas de Planta/imunologia , Plantas Geneticamente Modificadas , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/isolamento & purificação
7.
Proc Natl Acad Sci U S A ; 95(5): 2481-5, 1998 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-9482911

RESUMO

We previously demonstrated that recombinant plant virus particles containing a chimeric peptide representing two rabies virus epitopes stimulate virus neutralizing antibody synthesis in immunized mice. We show here that mice immunized intraperitoneally or orally (by gastric intubation or by feeding on virus-infected spinach leaves) with engineered plant virus particles containing rabies antigen mount a local and systemic immune response. After the third dose of antigen, given intraperitoneally, 40% of the mice were protected against challenge infection with a lethal dose of rabies virus. Oral administration of the antigen stimulated serum IgG and IgA synthesis and ameliorated the clinical signs caused by intranasal infection with an attenuated rabies virus strain.


Assuntos
Vacina Antirrábica , Raiva/imunologia , Vacinas Sintéticas , Administração Oral , Animais , Linhagem Celular , Cricetinae , Feminino , Engenharia Genética/métodos , Injeções Intraperitoneais , Camundongos , Plantas Geneticamente Modificadas , Plantas Tóxicas , Raiva/mortalidade , Raiva/prevenção & controle , Vacina Antirrábica/administração & dosagem , Spinacia oleracea , Fatores de Tempo , Nicotiana , Vírus do Mosaico do Tabaco , Vacinas Sintéticas/administração & dosagem
8.
J Virol ; 72(4): 3227-34, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9525649

RESUMO

An unusual and distinguishing feature of alfalfa mosaic virus (AMV) and ilarviruses such as tobacco streak virus (TSV) is that the viral coat protein is required to activate the early stages of viral RNA replication, a phenomenon known as genome activation. AMV-TSV coat protein homology is limited; however, they are functionally interchangeable in activating virus replication. For example, TSV coat protein will activate AMV RNA replication and vice versa. Although AMV and TSV coat proteins have little obvious amino acid homology, we recently reported that they share an N-terminal RNA binding consensus sequence (Ansel-McKinney et al., EMBO J. 15:5077-5084, 1996). Here, we biochemically compare the binding of chemically synthesized peptides that include the consensus RNA binding sequence and lysine-rich (AMV) or arginine-rich (TSV) environment to 3'-terminal TSV and AMV RNA fragments. The arginine-rich TSV coat protein peptide binds viral RNA with lower affinity than the lysine-rich AMV coat protein peptides; however, the ribose moieties protected from hydroxyl radical attack by the two different peptides are localized in the same area of the predicted RNA structures. When included in an infectious inoculum, both AMV and TSV 3'-terminal RNA fragments inhibited AMV RNA replication, while variant RNAs unable to bind coat protein did not affect replication significantly. The data suggest that RNA binding and genome activation functions may reside in the consensus RNA binding sequence that is apparently unique to AMV and ilarvirus coat proteins.


Assuntos
Vírus do Mosaico da Alfafa/metabolismo , Proteínas do Capsídeo , Capsídeo/metabolismo , Ilarvirus/metabolismo , Peptídeos/metabolismo , RNA Viral/metabolismo , Proteínas de Ligação a RNA/metabolismo , Sequência de Aminoácidos , Arginina/metabolismo , Sítios de Ligação , Capsídeo/síntese química , Lisina/metabolismo , Dados de Sequência Molecular , Conformação de Ácido Nucleico , Peptídeos/síntese química , Proteínas de Ligação a RNA/síntese química , Relação Estrutura-Atividade
9.
Virology ; 242(1): 1-5, 1998 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9501033

RESUMO

Infection of tobacco protoplasts with mutant alfalfa mosaic virus (AMV) RNAs indicated that three basic amino acids in the N-terminus of AMV coat protein are important for the biological activity of the coat protein in the beginning of infection. Substitution of alanines for lysines at position 14 or 17 in the coat protein resulted in a 5- or 10-fold reduction in the activity of the protein, respectively. However, substitution of alanine for arginine at position 18 entirely abolished activity. Arginine 18 was also required for the coat protein to bind to the 3' noncoding region of the virus RNA in vitro, whereas lysine 14 or 17 was not required. Thus, these results indicate that arginine 18 is essential for the activity of the coat protein in early infection and that binding of the coat protein to AMV RNA correlates with activity.


Assuntos
Vírus do Mosaico da Alfafa/química , Capsídeo/química , Vírus do Mosaico da Alfafa/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Capsídeo/biossíntese , Clonagem Molecular , Primers do DNA , Dados de Sequência Molecular , Plantas Tóxicas , Plasmídeos , Biossíntese de Proteínas , Protoplastos , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Nicotiana , Transcrição Gênica
10.
J Virol ; 71(10): 7911-6, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9311881

RESUMO

K. Fukuyama, S. S. Abdel-Meguid, J. E. Johnson, and M. G. Rossmann (J. Mol. Biol. 167:873-984, 1983) reported the structure of alfalfa mosaic virus assembled from the capsid protein as a T=1 icosahedral empty particle at 4.5-A resolution. The information contained in the structure included the particle size, protein shell thickness, presence of wide holes at the icosahedral fivefold axes, and a proposal that the capsid protein adopts a beta-barrel structure. In the present work, the X-ray diffraction data of Fukuyama et al. as well as the data subsequently collected by I. Fita, Y. Hata, and M. G. Rossmann (unpublished) were reprocessed to 4.0-A resolution, and the structure was solved by molecular replacement. The current structure allowed the tracing of the polypeptide chain of the capsid protein confirming the beta-sandwich fold and provides information on intersubunit interactions in the particle. However, it was not possible to definitively assign the amino acid sequence to the side chain density at 4-A resolution. The particle structure was also determined by cryoelectron microscopy and image reconstruction methods and found to be in excellent agreement with the X-ray model.


Assuntos
Vírus do Mosaico da Alfafa/ultraestrutura , Capsídeo/química , Capsídeo/ultraestrutura , Conformação Proteica , Vírus do Mosaico da Alfafa/química , Congelamento , Medicago sativa/virologia , Microscopia Eletrônica , Modelos Moleculares , Modelos Estruturais , Modelos Teóricos , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Difração de Raios X
11.
Proc Natl Acad Sci U S A ; 94(11): 5784-8, 1997 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-9159151

RESUMO

The coat protein (CP) of alfalfa mosaic virus was used as a carrier molecule to express antigenic peptides from rabies virus and HIV. The antigens were separately cloned into the reading frame of alfalfa mosaic virus CP and placed under the control of the subgenomic promoter of tobacco mosaic virus CP in the 30BRz vector. The in vitro transcripts of recombinant virus with sequences encoding the antigenic peptides were synthesized from DNA constructs and used to inoculate tobacco plants. The plant-produced protein (virus particles) was purified and used for immunization of mice. Both antigens elicited specific virus-neutralizing antibodies in immunized mice.


Assuntos
Vacinas contra a AIDS , Alfamovirus/genética , Anticorpos Antivirais/biossíntese , Antígenos Virais/imunologia , Anticorpos Anti-HIV/biossíntese , Antígenos HIV/imunologia , HIV-1/imunologia , Vacina Antirrábica , Vírus da Raiva/imunologia , Vacinas Sintéticas , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/sangue , Formação de Anticorpos , Antígenos Virais/biossíntese , Linfócitos B/imunologia , Sequência de Bases , Capsídeo/biossíntese , Linhagem Celular , Clonagem Molecular , Primers do DNA , Escherichia coli , Anticorpos Anti-HIV/sangue , Antígenos HIV/biossíntese , Vírus Linfotrópico T Tipo 1 Humano/imunologia , Humanos , Rim , Camundongos , Dados de Sequência Molecular , Testes de Neutralização , Regiões Promotoras Genéticas , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/imunologia , Linfócitos T/imunologia , Vírus do Mosaico do Tabaco/genética , Transcrição Gênica
12.
Proc Natl Acad Sci U S A ; 92(19): 8980-4, 1995 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-7568056

RESUMO

A virus-based vector was used for the transient expression of the alfalfa mosaic virus coat protein (CP) gene in protoplasts and plants. The accumulation of wild-type CP conferred strong protection against subsequent alfalfa mosaic virus infection, enabling the efficacy of CP mutants to be determined without developing transgenic plants. Expression of the CP mRNA alone without CP accumulation conferred weaker protection against infection. The activity of the N-terminal mutant CPs in protection did not correlate with their activities in genome activation. The activity of a C-terminal mutant suggested that encapsidation did not have a role in protection. Our results indicate that interaction of the CP with alfalfa mosaic virus RNA is not important in protection, thereby leaving open the possibility that interactions with host factors lead to protection.


Assuntos
Vírus do Mosaico da Alfafa/crescimento & desenvolvimento , Proteínas do Capsídeo , Capsídeo/farmacologia , Doenças das Plantas , RNA Viral/metabolismo , Proteínas de Ligação a RNA/farmacologia , Vírus do Mosaico da Alfafa/genética , Vírus do Mosaico da Alfafa/patogenicidade , Sequência de Aminoácidos , Sequência de Bases , Capsídeo/genética , Análise Mutacional de DNA , Dados de Sequência Molecular , Plantas Tóxicas , Protoplastos/virologia , Proteínas de Ligação a RNA/genética , Relação Estrutura-Atividade , Nicotiana/virologia , Virulência/efeitos dos fármacos
13.
Proc Natl Acad Sci U S A ; 91(8): 2994-8, 1994 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-8159693

RESUMO

During the inception of crown gall tumorigenesis, the transferred DNA (T-DNA) is processed from the Ti (tumor inducing) plasmid of Agrobacterium tumefaciens and is transferred to plant cells. T-DNA processing and transfer require the induction of vir (virulence) genes by phenolic compounds secreted by wounded plant cells. After vir gene induction, both single-stranded (T-strands) and double-stranded forms of processed T-DNA accumulate in the bacteria. Although current models favor the transfer of T-strands to plants, there has yet been no experimental evidence to show this. In this paper, we show that T-strands disappear from acetosyringone-induced A. tumefaciens within 30 min of bacterial cocultivation with tobacco protoplasts. PCR analysis of T-DNA associated with protoplasts indicates that single-stranded, but not double-stranded, T-DNA can be detected in the plant cells within 30 min of bacterial cocultivation. Control experiments show that this T-DNA does not originate from lysed contaminating bacterial cells. T-DNA transfer depends on a functional bacterial virB operon. Protoplast infections using an A. tumefaciens virE mutant result in a low level of accumulation of T-strands in the plant cells.


Assuntos
Agrobacterium tumefaciens/genética , DNA de Cadeia Simples/metabolismo , Técnicas de Transferência de Genes , Sequência de Bases , Células Cultivadas , Primers do DNA/química , Genes Bacterianos , Técnicas In Vitro , Dados de Sequência Molecular , Plantas Tóxicas , Plasmídeos , Nicotiana
14.
Plant Mol Biol ; 17(4): 825-36, 1991 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1912501

RESUMO

The tumour-inducing T-DNA gene 4 (T-cyt gene) of the nopaline Ti plasmid pTiC58 was cloned and introduced into tobacco cells by leaf disc transformation using Agrobacterium plasmid vectors. Tobacco shoots exposed to elevated cytokinin levels were unable to develop roots and lacked apical dominance. Using exogenously applied phytohormone manipulations we were able to regenerate morphologically normal transgenic tobacco plants which differed in endogenous cytokinin levels from normal untransformed plants. Although T-cyt gene mRNA levels, as revealed by dot-blot hybridization data, in these rooting plants were only about half those in primary transformed shoots the total amount of cytokinins was much lower than in crown gall tissue or cytokinin-type transformed shoots as reported by others. Nevertheless the cytokinin content in T-cyt plants was about 3 times greater than in control tobacco plants. Elevated cytokinin levels have been shown to change the expression of several plant genes, including some nuclear genes encoding chloroplast proteins. Our results show that the mRNA levels of chloroplast rbcL gene increase in cytokinin-type transgenic tobacco plants as compared with untransformed plants. Data obtained suggest that T-cyt transgenic plants are a good model for studying plant gene activity in different parts of the plant under endogenous cytokinin stress.


Assuntos
Citocininas/genética , Regulação da Expressão Gênica/genética , Nicotiana/genética , Plantas Geneticamente Modificadas/genética , Plantas Tóxicas , Plasmídeos/genética , Agrobacterium tumefaciens/genética , Northern Blotting , Southern Blotting , Clonagem Molecular , Conjugação Genética/genética , Citocininas/biossíntese , Citocininas/farmacologia , Escherichia coli/genética , Ácidos Indolacéticos/farmacologia , Modelos Biológicos , Fenótipo , Plantas Geneticamente Modificadas/efeitos dos fármacos , Plantas Geneticamente Modificadas/enzimologia , Ribulose-Bifosfato Carboxilase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA